Fundamentals
Have you ever felt a subtle shift in your body’s rhythm, a quiet insistence that something is not quite right, even when traditional markers appear within typical ranges? Perhaps you experience persistent fatigue, unexpected weight changes, or a general sense of imbalance that defies simple explanations. These sensations are not merely subjective; they often represent your body’s intricate communication systems signaling a need for attention.
Our biological systems operate through a complex network of messengers, and when these signals become distorted, the effects ripple across our entire well-being. Understanding these internal conversations is the first step toward reclaiming vitality and function.
For many, the journey toward optimal health begins with recognizing that symptoms are not isolated incidents. They are expressions of underlying biological mechanisms, a language our bodies speak to guide us toward deeper understanding. Consider the widespread discussion surrounding glucagon-like peptide-1 Meaning ∞ Glucagon-Like Peptide-1, commonly known as GLP-1, is an incretin hormone secreted by intestinal L-cells primarily in response to nutrient ingestion. (GLP-1) agonists.
These agents are widely recognized for their powerful effects on blood glucose regulation and weight management. Yet, their influence extends far beyond these primary actions, reaching into the complex interplay of our endocrine system html Meaning ∞ The endocrine system is a network of specialized glands that produce and secrete hormones directly into the bloodstream. and shaping our overall physiological equilibrium.
Understanding the body’s subtle signals is key to recognizing deeper biological imbalances.
The Body’s Internal Messaging System
Our bodies function as sophisticated communication networks, where hormones serve as vital messengers. These chemical signals travel through the bloodstream, relaying instructions to various organs and tissues. They orchestrate a vast array of processes, from metabolism and energy balance to mood regulation and reproductive function. When this delicate hormonal balance Meaning ∞ Hormonal balance describes the physiological state where endocrine glands produce and release hormones in optimal concentrations and ratios. is disrupted, a cascade of effects can ensue, impacting how we feel, how we metabolize nutrients, and how our bodies maintain stability.
The endocrine system, a collection of glands that produce and secrete hormones, acts as the central command center for these operations. It includes the thyroid, adrenal glands, pancreas, and reproductive organs, all working in concert. A disruption in one area can send reverberations throughout the entire system, much like a single faulty component in a complex machine can affect its overall performance.
Introducing GLP-1 Agonists
Glucagon-like peptide-1 is a natural hormone produced in the gut, released in response to food intake. Its primary role involves stimulating insulin secretion in a glucose-dependent manner, meaning insulin is released only when blood sugar levels are elevated. This mechanism helps to lower blood glucose without causing hypoglycemia when levels are already low. GLP-1 also slows gastric emptying, promoting a feeling of fullness, and reduces glucagon secretion, which further aids in glucose control.
GLP-1 receptor agonists Meaning ∞ Receptor agonists are molecules that bind to and activate specific cellular receptors, initiating a biological response. are medications designed to mimic the actions of this natural hormone. By activating GLP-1 receptors, these agents enhance the body’s natural ability to manage blood sugar and appetite. While their initial development focused on treating type 2 diabetes and obesity, scientific inquiry has revealed their broader physiological reach.
The receptors for GLP-1 are not confined to the pancreas; they are present in diverse tissues, including the gastrointestinal tract, heart, brain, and even reproductive organs. This widespread distribution hints at their capacity to influence numerous biological processes beyond simple glucose regulation.
Beyond Glucose Control
The impact of GLP-1 agonists Meaning ∞ GLP-1 Agonists are pharmaceutical compounds mimicking natural glucagon-like peptide-1, an incretin hormone. extends beyond their well-known effects on blood sugar and weight. Their presence in various bodily systems suggests a more profound interaction with the endocrine network. For instance, the ability of these agents to influence satiety and reduce appetite stems from their action on the brain’s appetite centers, particularly in the hypothalamus. This region of the brain is not only involved in hunger and satiety but also plays a significant role in regulating sexual desire and function, hinting at interconnected pathways.
The systemic improvements brought about by GLP-1 agonists, such as weight reduction and enhanced insulin sensitivity, can indirectly influence hormonal balance. Obesity and insulin resistance html Meaning ∞ Insulin resistance describes a physiological state where target cells, primarily in muscle, fat, and liver, respond poorly to insulin. often contribute to hormonal dysregulation, including altered sex hormone levels and increased inflammation. By addressing these underlying metabolic issues, GLP-1 agonists can help restore a more balanced hormonal profile, contributing to overall well-being.
Intermediate
As we move beyond the foundational understanding of GLP-1 agonists, a deeper exploration reveals their intricate connections within the body’s complex regulatory systems. These agents do not operate in isolation; they interact with and influence various endocrine axes, offering a more comprehensive approach to metabolic and hormonal health. The goal is not merely to manage symptoms but to recalibrate the body’s internal thermostat, restoring its innate intelligence.
Influence on Sex Hormones
The relationship between GLP-1 agonists and sex hormones presents a compelling area of study. In men, metabolic dysfunction, often characterized by insulin resistance and obesity, can suppress the hypothalamic-pituitary-gonadal (HPG) axis, leading to conditions like functional hypogonadism. This can manifest as low testosterone levels, reduced libido, and erectile dysfunction.
GLP-1 receptor agonists, by improving insulin sensitivity Meaning ∞ Insulin sensitivity refers to the degree to which cells in the body, particularly muscle, fat, and liver cells, respond effectively to insulin’s signal to take up glucose from the bloodstream. and lowering insulin levels, can help normalize this axis. Studies have documented increases in sex hormone-binding globulin (SHBG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in men receiving GLP-1 receptor agonists, suggesting a relief of metabolic inhibition on the pituitary-gonadal system.
Weight loss, a common outcome of GLP-1 agonist Meaning ∞ A GLP-1 Agonist is a medication class mimicking natural incretin hormone Glucagon-Like Peptide-1. These agents activate GLP-1 receptors, stimulating glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and enhancing satiety. therapy, also contributes significantly to improved testosterone levels and erectile function in men with metabolic dysfunction. The vasodilatory and anti-atherosclerotic effects of these agents can enhance penile blood flow, further supporting erectile function. While some research on healthy men showed no clinically relevant effect on sexual desire or gonad axis hormones, the benefits appear more pronounced in individuals with underlying metabolic issues.
GLP-1 agonists can improve sex hormone balance, particularly in individuals with metabolic dysfunction.
For women, GLP-1 receptor agonists GLP-1 receptor agonists recalibrate metabolic pathways, fostering systemic health and enhancing long-term vitality. show promise in managing hormonal disturbances, especially in conditions like polycystic ovary syndrome (PCOS). PCOS is often associated with insulin resistance, elevated androgen levels, and irregular menstrual cycles. GLP-1 receptor agonists enhance insulin sensitivity, which is closely linked to favorable changes in body composition, such as decreased BMI and waist circumference. These improvements are critical for women with PCOS who frequently present with obesity.
These agents modulate the hormonal environment in PCOS by contributing to a mild reduction in androgen levels, including total testosterone and dehydroepiandrosterone sulfate (DHEAS), while simultaneously increasing SHBG levels. These shifts help restore a more balanced hormonal profile, potentially mitigating the hyperandrogenism that underlies many PCOS symptoms. Additionally, GLP-1 receptor Meaning ∞ The GLP-1 Receptor is a crucial cell surface protein that specifically binds to glucagon-like peptide-1, a hormone primarily released from intestinal L-cells. agonists appear to influence menstrual cyclicity positively, promoting more regular ovulatory cycles and potentially improving fertility outcomes by influencing the hypothalamic-pituitary-ovarian axis.
Thyroid Gland Interactions
The thyroid gland, a central regulator of metabolism, also experiences the influence of GLP-1 receptor agonists. The relationship between these medications and thyroid function Meaning ∞ Thyroid function refers to the physiological processes by which the thyroid gland produces, stores, and releases thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3), essential for regulating the body’s metabolic rate and energy utilization. is an area of ongoing investigation. Some meta-analyses suggest a potential increase in the risk of overall thyroid disorders, with a reported 28% higher risk compared to placebo or other interventions, particularly with liraglutide and dulaglutide.
However, other studies present conflicting results, indicating no significant increase in the risk of thyroid cancer in humans, despite observations in rodent models showing C-cell proliferation. The current evidence remains inconclusive, emphasizing the need for longer-term studies with larger sample sizes to draw clearer conclusions. Given this evolving understanding, it is advisable to include thyroid function tests in the routine screening of individuals receiving GLP-1 receptor agonists, especially those with pre-existing metabolic conditions.
The Hypothalamic-Pituitary-Adrenal Axis
The hypothalamic-pituitary-adrenal (HPA) axis, often referred to as the body’s stress response system, also interacts with GLP-1 receptor agonists. Acute administration of GLP-1 receptor agonists has been shown to activate the HPA axis, leading to increases in adrenocorticotropic hormone (ACTH) and cortisol levels in humans. This suggests a role for these agents in modulating the body’s response to stress.
GLP-1 receptors are present in the hypothalamus and pituitary gland, key components of the HPA axis html Meaning ∞ The HPA Axis, or Hypothalamic-Pituitary-Adrenal Axis, is a fundamental neuroendocrine system orchestrating the body’s adaptive responses to stressors. . The effects on this axis might partially explain improvements seen in conditions associated with HPA axis dysregulation, such as obesity, metabolic syndrome, and certain mood disorders. While these effects are generally not associated with adrenal insufficiency at standard therapeutic doses, close monitoring is prudent for individuals with pre-existing adrenal conditions.
Protocols and Peptides in Hormonal Optimization
The broader landscape of personalized wellness Meaning ∞ Personalized Wellness represents a clinical approach that tailors health interventions to an individual’s unique biological, genetic, lifestyle, and environmental factors. protocols, including hormone replacement therapy (HRT) and peptide therapy, offers additional avenues for supporting hormonal equilibrium. While GLP-1 agonists address specific metabolic pathways, these other protocols target distinct aspects of endocrine function.
For men experiencing symptoms of low testosterone, Testosterone Replacement Therapy (TRT) often involves weekly intramuscular injections of Testosterone Cypionate. This is frequently combined with other agents to maintain natural production and manage side effects. For instance, Gonadorelin, administered subcutaneously twice weekly, aims to support the body’s intrinsic testosterone production and preserve fertility.
Anastrozole, an oral tablet taken twice weekly, helps to block the conversion of testosterone to estrogen, mitigating potential adverse effects. In some cases, Enclomiphene may be included to further support LH and FSH levels, which are crucial for testicular function.
Women navigating hormonal changes, such as those in peri-menopause or post-menopause, may benefit from tailored hormonal optimization protocols. These can include subcutaneous injections of Testosterone Cypionate, typically in low doses (e.g. 10–20 units weekly), to address symptoms like low libido or mood changes.
Progesterone is often prescribed based on menopausal status to support uterine health and hormonal balance. Long-acting testosterone pellets, sometimes combined with Anastrozole, offer an alternative delivery method for sustained hormonal support.
Peptide therapies represent another frontier in personalized wellness, targeting specific physiological functions.
- Sermorelin, Ipamorelin / CJC-1295, Tesamorelin, and Hexarelin are examples of growth hormone-releasing peptides. These agents stimulate the body’s natural production of growth hormone, which can contribute to anti-aging effects, muscle gain, fat loss, and improved sleep quality.
- MK-677, an oral growth hormone secretagogue, offers similar benefits by increasing growth hormone and IGF-1 levels.
- PT-141 is a peptide specifically used for sexual health, addressing issues related to libido and arousal.
- Pentadeca Arginate (PDA) is recognized for its role in tissue repair, accelerating healing processes, and reducing inflammation.
These protocols, while distinct from GLP-1 agonist therapy, share a common goal ∞ restoring systemic balance. The comprehensive approach to wellness often involves considering how various interventions can synergistically support the body’s complex endocrine and metabolic machinery.
Academic
The scientific understanding of GLP-1 agonists extends into the intricate molecular and cellular mechanisms that govern long-term hormonal equilibrium. Moving beyond their direct effects on glucose and weight, these agents exert pleiotropic actions that reverberate throughout the endocrine system, influencing metabolic pathways, inflammatory responses, and even neuroendocrine axes. This deeper analysis requires a systems-biology perspective, recognizing the interconnectedness of all physiological processes.
The Interplay with Metabolic Pathways
GLP-1 receptor agonists significantly influence metabolic pathways Meaning ∞ Metabolic pathways represent organized sequences of biochemical reactions occurring within cells, where a starting molecule is progressively transformed through a series of enzyme-catalyzed steps into a final product. beyond glucose homeostasis. Their capacity to improve insulin sensitivity is a cornerstone of their broader metabolic benefits. By enhancing insulin signaling in adipose tissue, these medications lead to improved glucose metabolism and reduced fat accumulation. This is particularly relevant in conditions characterized by insulin resistance, such as type 2 diabetes and metabolic syndrome.
Beyond glucose, GLP-1 receptor agonists positively influence lipid metabolism. They are associated with reductions in triglyceride levels and improvements in lipid profiles among individuals with obesity or type 2 diabetes. This effect contributes to a reduction in atherogenic dyslipidemia, a key risk factor for cardiovascular disease often linked to insulin resistance and chronic inflammation. The reduction in hepatic fat accumulation and improvement in liver health, particularly in cases of non-alcoholic fatty liver disease (NAFLD), further underscore their systemic metabolic impact.
GLP-1 agonists recalibrate metabolic function, improving insulin sensitivity and lipid profiles.
Modulation of Inflammatory Processes
Chronic low-grade inflammation is a pervasive factor in many metabolic and hormonal dysregulations. GLP-1 receptor agonists exhibit significant anti-inflammatory properties, contributing to their wide-ranging health benefits. Clinical studies and meta-analyses consistently show that these agents reduce systemic inflammatory markers.
For instance, a major meta-analysis confirmed that GLP-1 receptor agonists significantly GLP-1 receptor agonists recalibrate metabolic pathways, fostering systemic health and enhancing long-term vitality. reduced levels of C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β). Simultaneously, they increased levels of adiponectin, a protective hormone known for its anti-inflammatory and insulin-sensitizing effects. These changes indicate a shift in the body’s inflammatory landscape, which helps explain their cardiovascular and metabolic advantages.
The anti-inflammatory action of GLP-1 receptor agonists is not limited to the bloodstream. They target multiple inflammatory pathways across various tissues, including the pancreas, gut, liver, and even the nervous system. This broad anti-inflammatory effect suggests potential benefits in chronic conditions beyond diabetes, such as cardiovascular disease, kidney dysfunction, and potentially autoimmune disorders. The mechanism involves modulating immune cells and downregulating pro-inflammatory cytokine production.
Neuroendocrine Axis Interactions
The brain’s role in orchestrating hormonal balance cannot be overstated. GLP-1 receptors are expressed in various brain regions, including the hypothalamus and brainstem, which are critical for appetite regulation, reward systems, and neuroendocrine control. This central action allows GLP-1 receptor agonists to influence not only feeding behavior but also other motivated behaviors, including sexual desire.
The interaction with the HPA axis, as previously discussed, highlights the influence of GLP-1 receptor agonists on stress physiology. The activation of the HPA axis by these agents, leading to increased ACTH and cortisol, suggests a complex role in integrating metabolic signals with stress responses. This connection implies that GLP-1 receptor agonists may help recalibrate the stress response, which is often dysregulated in metabolic conditions.
The interplay between GLP-1 signaling and other neuroendocrine systems, such as the growth hormone/IGF-1 axis, is also under investigation. While more research is needed, it is reasonable to consider that the metabolic improvements and anti-inflammatory effects of GLP-1 receptor agonists could indirectly influence growth hormone Meaning ∞ Growth hormone, or somatotropin, is a peptide hormone synthesized by the anterior pituitary gland, essential for stimulating cellular reproduction, regeneration, and somatic growth. and IGF-1 levels, which are crucial for tissue repair, metabolism, and overall vitality.
What Are the Long-Term Implications for Endocrine Health?
The long-term implications of GLP-1 agonist therapy Microbial biomarkers offer a path to personalize GLP-1 agonist therapy, optimizing metabolic outcomes through gut ecosystem insights. on hormonal equilibrium extend beyond immediate glucose and weight management. The sustained improvements in insulin sensitivity, reduction in systemic inflammation, and positive modulation of sex hormone profiles can contribute to a more stable and functional endocrine system over time. For individuals with conditions like PCOS, the restoration of regular menstrual cycles and reduction in androgen levels can have profound effects on reproductive health and overall quality of life.
However, the evolving understanding of their effects on the thyroid gland underscores the necessity for continued vigilance and personalized monitoring. While concerns about thyroid cancer risk have been largely alleviated in human studies compared to rodent models, the potential for other thyroid disorders warrants careful consideration and routine screening. This highlights the dynamic nature of clinical science, where new insights continually refine our understanding of therapeutic interventions.
The systemic effects of GLP-1 receptor agonists on inflammation and metabolic health also suggest a protective role against age-related decline and chronic disease progression. By mitigating factors like oxidative stress and chronic inflammation, these agents may contribute to healthier aging and improved longevity. The ongoing research into their neuroprotective effects and influence on mood disorders further expands their potential impact on overall well-being, suggesting a broader role in supporting mental and cognitive health alongside physical vitality.
The integration of GLP-1 agonist therapy within a comprehensive personalized wellness protocol, which may include targeted hormone replacement therapies and peptide interventions, represents a sophisticated approach to optimizing health. By addressing the root causes of metabolic and hormonal dysregulation, individuals can experience a more profound and lasting improvement in their vitality and function.
| Hormonal Axis/System | GLP-1 Agonist Influence | Observed Effects |
|---|---|---|
| Hypothalamic-Pituitary-Gonadal (HPG) Axis | Indirect modulation via metabolic improvements | Increased SHBG, LH, FSH in men; reduced androgens, improved menstrual regularity in women with PCOS |
| Thyroid Function | Direct and indirect effects, area of ongoing research | Potential increased risk of overall thyroid disorders (e.g. with liraglutide, dulaglutide); inconclusive data on thyroid cancer risk in humans |
| Hypothalamic-Pituitary-Adrenal (HPA) Axis | Direct activation, modulation of stress response | Increased ACTH and cortisol levels (acute administration); potential for improved HPA axis dysregulation in metabolic conditions |
| Metabolic Hormones (Insulin, Glucagon) | Direct action on pancreatic cells | Glucose-dependent insulin secretion, glucagon inhibition, improved insulin sensitivity |
| Adipokines (Adiponectin) | Indirect modulation via metabolic and anti-inflammatory effects | Increased adiponectin levels, contributing to anti-inflammatory and insulin-sensitizing effects |
This table summarizes the known and suspected influences of GLP-1 receptor agonists on various hormonal axes and systems, highlighting the breadth of their physiological impact beyond glucose control.
References
- Gilbert, B. R. (2024). GLP-1 Agonists in Men ∞ Effects on Testosterone, Sperm, and Sexual Function. Bruce R Gilbert MD, PhD, PC.
- IntimMedicine Specialists. (2024). Beyond Weight Loss ∞ How GLP-1 Agonists (Ozempic, Wegovy) Influence Sexual Desire and Function. IntimMedicine Specialists.
- Hofmann, S. et al. (2023). Effects of Glucagon-Like Peptide-1 Analogs on Sexual Desire ∞ A randomized, double-blind, placebo-controlled crossover trial. Endocrine Abstracts, 25th European Congress of Endocrinology.
- Yabut, J. M. & Drucker, D. J. (2023). Glucagon-Like Peptide-1 Receptor-Based Therapeutics for Metabolic Liver Disease. Endocrine Reviews, 44(1), 14-32.
- Ren, Y. et al. (2025). The Effect of GLP-1 Receptor Agonists on Circulating Inflammatory Markers in Type 2 Diabetes Patients ∞ A Systematic Review and Meta-Analysis. Diabetes, Obesity & Metabolism.
- Bray, J. J. H. et al. (2021). Glucagon-Like Peptide-1 Receptor Agonists Improve Biomarkers of Inflammation and Oxidative Stress ∞ A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Diabetes, Obesity & Metabolism, 23(8), 1806-1822.
- Bendotti, G. et al. (2022). The Anti-Inflammatory and Immunological Properties of GLP-1 Receptor Agonists. Pharmacological Research, 182, 106320.
- Zhang, S. et al. (2022). Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders ∞ a Meta-Analysis of Randomized Controlled Trials. Frontiers in Endocrinology, 13, 934570.
- Al-Hamad, S. et al. (2024). Implications of GLP-1 Receptor Agonist on Thyroid Function ∞ A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels. Journal of Clinical Medicine, 13(12), 3479.
- Cleveland Clinic Journal of Medicine. (2012). Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists? Cleveland Clinic Journal of Medicine, 79(1), 53-56.
- Hofmann, S. et al. (2018). Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy Volunteers. The Journal of Clinical Endocrinology & Metabolism, 103(12), 4485-4493.
- Smits, M. M. & Van Raalte, D. H. (2021). Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress. International Journal of Molecular Sciences, 22(12), 6479.
- Dr.Oracle AI. (2025). What is the effect of Glucagon-like peptide-1 (GLP-1) inhibitors on the Hypothalamic-Pituitary-Adrenal (HPA) axis? Dr.Oracle AI.
- Cignarelli, A. et al. (2022). Mini Review ∞ Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis. Frontiers in Endocrinology, 13, 847976.
- Sargazi, M. et al. (2023). An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome ∞ A drug repositioning. Journal of Diabetes & Metabolic Disorders, 22(1), 1-10.
- SheMed Blog. (2024). GLP-1 Medications and Hormonal Balance in Women. SheMed Blog.
- MDPI. (2025). The Expanding Role of GLP-1 Receptor Agonists ∞ Advancing Clinical Outcomes in Metabolic and Mental Health. MDPI.
- MDPI. (2025). Anti-Inflammatory and Anti-Oxidative Effects of GLP1-RAs and SGLT2i ∞ The Guiding Star Towards Cardiovascular Protection in Type 2 Diabetes. MDPI.
- Frontiers. (2023). GLP-1 Receptor Agonists ∞ Beyond Their Pancreatic Effects. Frontiers in Endocrinology.
- SheMed Blog. (2024). GLP-1 Medications and Hormonal Balance in Women. SheMed Blog.
- MDPI. (2025). Mechanisms of action of GLP-1 agonists in appetite and metabolism regulation. MDPI.
- MDPI. (2025). The Unexpected Effects of GLP-1 Medications on Women’s Health. MDPI.
- Oxford Academic. (2021). GLP-1 and Its Analogs ∞ Does Sex Matter? Endocrinology.
Reflection
The journey into understanding GLP-1 agonists Managing GLP-1 agonist nausea involves optimizing gastric transit, supporting gut-brain axis balance, and harmonizing overall endocrine function for enhanced systemic resilience. and their far-reaching effects on hormonal equilibrium is a testament to the body’s profound interconnectedness. This exploration moves beyond a simple focus on blood sugar, inviting a deeper consideration of how various biological systems communicate and influence one another. The knowledge gained here is not merely academic; it is a tool for introspection, a lens through which to view your own health journey with greater clarity and purpose.
Recognizing the subtle yet significant ways these agents interact with sex hormones, thyroid function, and stress responses opens new pathways for personalized wellness. Your unique biological system responds to interventions in its own way, reflecting a complex interplay of genetics, lifestyle, and environment. This understanding encourages a proactive stance, prompting questions about how you can best support your own vitality.
Your Personal Health Blueprint
Every individual possesses a distinct biological blueprint. The insights into GLP-1 agonists serve as a reminder that true health optimization involves a tailored approach, one that respects your personal physiology. This means considering how interventions align with your body’s inherent wisdom, rather than applying a one-size-fits-all solution. The goal is to fine-tune your internal systems, allowing them to operate with greater efficiency and resilience.
Consider this information a starting point for a conversation with your healthcare provider. Discussing your symptoms, concerns, and goals within the context of these complex biological interactions can lead to more precise and effective strategies. The path to reclaiming vitality is often a collaborative one, guided by scientific understanding and a deep respect for your lived experience.